BIO Association News
Registration now open for 2010 BIO Asia Partnering Conference
BIO SmartBrief | Nov 06, 2009
The seventh annual BIO Asia Partnering Conference 2010, to be held Jan. 25 and 26 in Tokyo, is the leading biotechnology conference in Asia. This exclusive, customized partnering forum, hosted by the BIO and BioCentury Publications, brings together U.S. and European drug-development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements. New this year -- company presentations. Register for and apply to present at the 2010 BIO Asia Partnering Conference.
Grant-funding opportunities
BIO SmartBrief | Nov 05, 2009
In this tough funding climate, biotech companies must be even more diligent at looking for new sources of capital. BIO has partnered with FreeMind Group, a firm specializing in raising funds from government agencies through grants and contracts. In 2008, FreeMind Group assisted companies in winning over $300 million in grants and contracts for its clients, including small, midsize and large life sciences companies. As a BIO member, your company can take advantage of FreeMind's grant identification and application assistance at a discounted rate of 20% off upfront fees. Learn more.
Looking for new strategies for managing your company's cash flow during this economic lull?
BIO SmartBrief | Nov 04, 2009
Now is the time to check out BIO Business Solutions, BIO's cost-savings program. With 15 money-saving opportunities with leading providers in the biotech industry, saving your company money is made easier with BIO Business Solutions. Participation is free to members of BIO and 38 state/regional biotech associations. Get a complete list of the products and services available to you here.
Feeling the pinch in today's market hurts
BIO SmartBrief | Nov 03, 2009
Let BIO ease your pain with BIO Business Solutions, BIO's cost-savings program, which provides products and services specific to the life sciences industry at discounted prices and other benefits. Participation is free to members of BIO and 38 state/regional biotech associations, and more than 1,900 companies currently use BIO Business Solutions. See how BIO Business Solutions can help your bottom line. Get more information about the 15 money-saving opportunities here.
Honolulu says "Aloha" to industrial biotechnology
BIO SmartBrief | Oct 30, 2009
BIO is pleased to announce the fourth annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy, Nov. 8 to 11 in Honolulu. The latest issues in industrial biotechnology will be featured, including algae for fuels, renewable chemicals and bio-based materials, biofuels and bioenergy technologies, specialty crops, renewable feedstocks, and sustainability commercialization: policies and business models, and much more. More information.
Greater breadth of companies. Greater depth of knowledge.
BIO SmartBrief | Oct 27, 2009
The BIO Investor Forum, Oct. 28 to 29 in San Francisco, is a national investor forum exploring investment trends and opportunities in life sciences. Hear presentations from more than 110 late-stage private and emerging public companies you won't see at other investor conferences. Meet one on one with new and current investors, analysts and partnering companies. Gain insights from expert physicians, analysts and company scientific officers at candid therapeutic and business panels. For program and participant updates and more information, visit the BIO Investor Forum Web site.
Sign up for BIO SmartBrief
Latest Blog Postsview more
Ants are friendly to some trees, but not others
Science Blog
AIBS publishes Darwin articles open access
Science Blog
Higher carotid arterial stenting rates associated with poorer clinical outcomes
Science Blog
AIBS publishes Darwin articles open access
Science Blog
Companies in the news
- Abbott Laboratories
- Amylin Pharmaceuticals Inc.
- Exelixis Inc
- Genzyme
- GlaxoSmithKline plc
- IVAX Pharmaceuticals
- Johnson & Johnson
- Lilly
- Merck & Co., Inc.
- Novartis
- Novartis AG
- Pozen
- Schering-Plough
- Teva Pharmaceutical Industries
- Watson Pharmaceuticals
